{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:06:21Z","timestamp":1771952781094,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010809","name":"Jascha Foundation","doi-asserted-by":"publisher","award":["2022-0278"],"award-info":[{"award-number":["2022-0278"]}],"id":[{"id":"10.13039\/100010809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004196","name":"Odense Universitetshospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024075","name":"Region Syddanmark","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R434-2023-342"],"award-info":[{"award-number":["R434-2023-342"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.yebeh.2026.110940","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T08:07:50Z","timestamp":1771315670000},"page":"110940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dose\u2013response analysis of valproate, levetiracetam and lamotrigine in idiopathic generalized epilepsy"],"prefix":"10.1016","volume":"177","author":[{"given":"Amine","family":"Abdullah-Roskj\u00e6r","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Gesche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Rubboli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8268-1492","authenticated-orcid":false,"given":"Christoph P.","family":"Beier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.yebeh.2026.110940_b0005","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1007\/s00415-023-11834-8","article-title":"Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis","volume":"270","author":"Chu","year":"2023","journal-title":"J Neurol"},{"issue":"18","key":"10.1016\/j.yebeh.2026.110940_b0010","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000010644","article-title":"Patterns and prognostic markers for treatment response in generalized epilepsies","volume":"95","author":"Gesche","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.110940_b0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.seizure.2020.12.005","article-title":"Alternatives to valproate in girls and women of childbearing potential with Idiopathic Generalized Epilepsies: state of the art and guidance for the clinician proposed by the Epilepsy and Gender Commission of the Italian League against Epilepsy (LICE)","volume":"85","author":"Mostacci","year":"2021","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.yebeh.2026.110940_b0020","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/epi.17236","article-title":"ILAE definition of the idiopathic generalized epilepsy syndromes: position statement by the ILAE task force on nosology and definitions","volume":"63","author":"Hirsch","year":"2022","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2026.110940_b0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","article-title":"Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.yebeh.2026.110940_b0030","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.yebeh.2026.110940_b0035","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1111\/epi.17410","article-title":"Drug resistance in idiopathic generalized epilepsies: evidence and concepts","volume":"63","author":"Gesche","year":"2022","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2026.110940_b0040","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jsps.2022.12.001","article-title":"A comprehensive review on pharmacological applications and drug-induced toxicity of valproic acid","volume":"31","author":"Safdar","year":"2023","journal-title":"Saudi Pharm J"},{"issue":"10","key":"10.1016\/j.yebeh.2026.110940_b0045","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2174\/1570159X17666181227165722","article-title":"Valproic acid and epilepsy: from molecular mechanisms to clinical evidences","volume":"17","author":"Romoli","year":"2019","journal-title":"Curr Neuropharmacol"},{"issue":"5","key":"10.1016\/j.yebeh.2026.110940_b0050","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/epi.14701","article-title":"A single\u2010center, open\u2010label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers","volume":"60","author":"Finnema","year":"2019","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.yebeh.2026.110940_b0055","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1007\/s00259-024-06759-x","article-title":"Assessment of cerebral drug occupancy in humans using a single PET-scan: a [11C]UCB-J PET study","volume":"51","author":"Marstrand-Joergensen","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.yebeh.2026.110940_b0060","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1212\/WNL.43.11.2284","article-title":"Placebo\u2010controlled study of the efficacy and safety of lamotrigine in patients with partial seizures","volume":"43","author":"Matsuo","year":"1993","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2026.110940_b0065","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1038\/s41467-023-38942-3","article-title":"Structural mapping of Nav1.7 antagonists","volume":"14","author":"Wu","year":"2023","journal-title":"Nat Commun"},{"issue":"41","key":"10.1016\/j.yebeh.2026.110940_b0070","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309773120","article-title":"Dual-pocket inhibition of Na v channels by the antiepileptic drug lamotrigine","volume":"120","author":"Huang","year":"2023","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"10.1016\/j.yebeh.2026.110940_b0075","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF00373920","article-title":"Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones","volume":"430","author":"Xie","year":"1995","journal-title":"Pflgers Archiv Eur J Physiol"},{"issue":"6","key":"10.1016\/j.yebeh.2026.110940_b0080","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/sj.bjp.0701221","article-title":"Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones","volume":"121","author":"Kuo","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.yebeh.2026.110940_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106547","article-title":"Risk factors of paradoxical reactions to anti-seizure medication in genetic generalized epilepsy","volume":"170","author":"Gesche","year":"2021","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2026.110940_b0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.seizure.2020.11.005","article-title":"Unanticipated improvement in seizure control in drug-resistant epilepsy- real world observations","volume":"84","author":"Moloney","year":"2021","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.yebeh.2026.110940_b0095","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209921","article-title":"Prodromal phase of idiopathic generalized epilepsy","volume":"103","author":"Gesche","year":"2024","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.yebeh.2026.110940_b0100","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/epi.17930","article-title":"Over\u2010 and underreporting of seizures: how big is the problem?","volume":"65","author":"Hannon","year":"2024","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.yebeh.2026.110940_b0105","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1684\/epd.2021.1325","article-title":"Evaluation of absences and myoclonic seizures in adults with genetic (idiopathic) generalized epilepsy: a comparison between self\u2010evaluation and objective evaluation based on home video\u2010EEG telemetry","volume":"23","author":"Elmali","year":"2021","journal-title":"Epileptic Disord"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026000612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026000612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:29:05Z","timestamp":1771950545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505026000612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":21,"alternative-id":["S1525505026000612"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.110940","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose\u2013response analysis of valproate, levetiracetam and lamotrigine in idiopathic generalized epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.110940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110940"}}